Edition:
United States

HBM Healthcare Investments AG (HBMN.S)

HBMN.S on Swiss Exchange

129.70CHF
11:29am EST
Change (% chg)

CHF1.20 (+0.93%)
Prev Close
CHF128.50
Open
CHF128.50
Day's High
CHF129.80
Day's Low
CHF128.50
Volume
7,791
Avg. Vol
7,869
52-wk High
CHF132.00
52-wk Low
CHF98.00

Latest Key Developments (Source: Significant Developments)

CSL And HBM Portfolio Company Vitaeris Announce Strategic Partnership
Tuesday, 5 Dec 2017 12:12pm EST 

Dec 5 (Reuters) - HBM HEALTHCARE INVESTMENTS ::CSL AND HBM PORTFOLIO COMPANY VITAERIS ANNOUNCE STRATEGIC PARTNERSHIP WITH OPTION TO ACQUIRE.  Full Article

BaseHealth raises $8.5 mln in Series C funding
Wednesday, 18 Oct 2017 07:00am EDT 

Oct 18 (Reuters) - BaseHealth:BaseHealth raises $8.5 million in Series C funding.BaseHealth - ‍overall investment of $8.5 million includes $2.5 million from lead investor HBM Healthcare Investments ​.  Full Article

HBM Healthcare Investments announces investment of $30 mln in Harmony Biosciences‍​
Friday, 6 Oct 2017 12:30am EDT 

Oct 6 (Reuters) - HBM HEALTHCARE INVESTMENTS AG ::ANNOUNCES INVESTMENT OF USD 30 MILLION IN HARMONY BIOSCIENCES‍​.  Full Article

HBM Healthcare Investments Q1 loss at CHF 72 million
Tuesday, 25 Jul 2017 12:32am EDT 

July 25 (Reuters) - HBM HEALTHCARE INVESTMENTS AG :Q1 LOSS 72 MILLION CHF.  Full Article

HBM Healthcare Investments FY net profit up at CHF 136.8 million
Tuesday, 16 May 2017 12:40am EDT 

May 16 (Reuters) - HBM HEALTHCARE INVESTMENTS AG ::PROPOSING AN INCREASE IN THE CASH DIVIDEND OF 30 CENTIMES, TO CHF 5.80 PER SHARE.EXPECTS THE LUTATHERA CANCER DRUG TO BE APPROVED TOWARDS THE END OF 2017.FY NET PROFIT OF CHF 136.8 MILLION VERSUS CHF 23.8 MILLION YEAR AGO.WILL CONTINUE TO MAKE SHAREHOLDER-FRIENDLY DISTRIBUTIONS AND SHARE BUY-BACKS.  Full Article

HBM Healthcare Investments commits EUR 20 mln in Amicus SA
Thursday, 27 Apr 2017 12:48am EDT 

April 27 (Reuters) - HBM Healthcare Investments AG ::Commits 20 million euros ($21.81 million) in growth capital to Switzerland based Amicus SA.Announced closing of a new equity investment of 20 million euros in two tranches into privately held and Switzerland based Amicus SA.Financing will allow Amicus to accelerate growth of its pharmaceutical business in Central and Eastern Europe (CEE).  Full Article

HBM Healthcare Investments FY net profit of around CHF 136 million
Tuesday, 4 Apr 2017 02:09am EDT 

HBM Healthcare Investments AG :Said on Monday expects to report a net profit of around 136 million Swiss francs ($135.76 million)for the financial year 2016/2017.  Full Article

HBM Healthcare Investments launches new share buy-back programme
Tuesday, 4 Oct 2016 12:38am EDT 

HBM Healthcare Investments AG : Launches a new share buy-back programme . New share buy-back programme of up to 730,000 shares (10 pct of total shares issued) for purpose of cancellation by way of a capital reduction .It will begin on Thursday, 6 October 2016 and will be terminated no later than 23 June 2019.  Full Article

HBM Healthcare Investments expects net profit of CHF 24 mln for first semester 2016/2017
Monday, 3 Oct 2016 12:19pm EDT 

HBM Healthcare Investments AG :For the first semester of the financial year 2016/2017, HBM Healthcare Investments expects to report a net profit of 24 million Swiss francs ($24.65 million).  Full Article

HBM Healthcare Investments terminates share buy-back programme 2014
Friday, 30 Sep 2016 11:35am EDT 

HBM Healthcare Investments AG :HBM Healthcare Investments terminates share buy-back programme 2014.  Full Article

BRIEF-CSL And HBM Portfolio Company Vitaeris Announce Strategic Partnership

* CSL AND HBM PORTFOLIO COMPANY VITAERIS ANNOUNCE STRATEGIC PARTNERSHIP WITH OPTION TO ACQUIRE Source text - http://bit.ly/2jhdF6b Further company coverage: (Gdynia Newsroom)